| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Division of Cancer Biology and Department of Medicine, ENH Research Institute, and 2 Division of Molecular Oncology and 3 Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Evanston, Illinois; and 4 Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, Maryland
Requests for reprints: Goberdhan P. Dimri, ENH Research Institute, 1001 University Place, Evanston, IL 60201. Phone: 224-364-7521; Fax: 224-364-7402; E-mail: g-dimri{at}northwestern.edu or Jeffrey E. Green, Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD 20892. Phone: 301-435-5193; Fax: 301-496-8709; E-mail: jegreen{at}nih.gov.
Elevated expression of Bmi-1 is associated with many cancers, including breast cancer. Here, we examined the oncogenic potential of Bmi-1 in MCF10A cells, a spontaneously immortalized, nontransformed strain of human mammary epithelial cells (HMEC). Bmi-1 overexpression alone in MCF10A cells did not result in oncogenic transformation. However, Bmi-1 co-overexpression with activated H-Ras (RasG12V) resulted in efficient transformation of MCF10A cells in vitro. Although early-passage H-Ras–expressing MCF10A cells were not transformed, late-passage H-Ras–expressing cells exhibited features of transformation in vitro. Early- and late-passage H-Ras–expressing cells also differed in levels of expression of H-Ras and Ki-67, a marker of proliferation. Subsets of early-passage H-Ras–expressing cells exhibited high Ras expression and were negative for Ki-67, whereas most late-passage H-Ras–expressing cells expressed low levels of Ras and were Ki-67 positive. Injection of late-passage H-Ras–expressing cells in severe combined immunodeficient mice formed carcinomas with leiomatous, hemangiomatous, and mast cell components; these tumors were quite distinct from those induced by late-passage cells co-overexpressing Bmi-1 and H-Ras, which formed poorly differentiated carcinomas with spindle cell features. Bmi-1 and H-Ras co-overexpression in MCF10A cells also induced features of epithelial-to-mesenchymal transition. Importantly, Bmi-1 inhibited senescence and permitted proliferation of cells expressing high levels of Ras. Examination of various growth-regulatory pathways suggested that Bmi-1 overexpression together with H-Ras promotes HMEC transformation and breast oncogenesis by deregulation of multiple growth-regulatory pathways by p16INK4a-independent mechanisms. [Cancer Res 2007;67(21):10286–95]
This article has been cited by other articles:
![]() |
J. Li, L.-Y. Gong, L.-B. Song, L.-L. Jiang, L.-P. Liu, J. Wu, J. Yuan, J.-C. Cai, M. He, L. Wang, et al. Oncoprotein Bmi-1 Renders Apoptotic Resistance to Glioma Cells through Activation of the IKK-Nuclear Factor-{kappa}B Pathway Am. J. Pathol., February 1, 2010; 176(2): 699 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Hoenerhoff, H. H. Hong, T.-v. Ton, S. A. Lahousse, and R. C. Sills A Review of the Molecular Mechanisms of Chemically Induced Neoplasia in Rat and Mouse Models in National Toxicology Program Bioassays and Their Relevance to Human Cancer Toxicol Pathol, December 1, 2009; 37(7): 835 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Xu, S. Lee, C. Ho, P. Bommi, S.-A. Huang, S. T. Cheung, G. P. Dimri, and X. Chen Bmi1 Functions as an Oncogene Independent of Ink4A/Arf Repression in Hepatic Carcinogenesis Mol. Cancer Res., December 1, 2009; 7(12): 1937 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tzatsos, R. Pfau, S. C. Kampranis, and P. N. Tsichlis Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus PNAS, February 24, 2009; 106(8): 2641 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Douglas, J. H.-R. Hsu, L. Hung, A. Cooper, D. Abdueva, J. van Doorninck, G. Peng, H. Shimada, T. J. Triche, and E. R. Lawlor BMI-1 Promotes Ewing Sarcoma Tumorigenicity Independent of CDKN2A Repression Cancer Res., August 15, 2008; 68(16): 6507 - 6515. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |